Tower Research Capital (TRC)’s Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 VLD.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-17
Closed 6079
2024
Q2
$0 Hold
17
﹤0.01% 6091
2024
Q1
$1 Hold
17
﹤0.01% 5827
2023
Q4
$1 Hold
17
﹤0.01% 5899
2023
Q3
$4 Hold
17
﹤0.01% 5895
2023
Q2
$6 Hold
17
﹤0.01% 5974
2023
Q1
$0 Hold
17
﹤0.01% 6438
2022
Q4
$0 Sell
17
-8
-32% -$4 ﹤0.01% 6525
2022
Q3
$0 Buy
+25
New +$18 ﹤0.01% 6612

Tower Research Capital (TRC)'s VLD.WS Position: Q3 2024 in Review

Tower Research Capital (TRC) sold out of Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (VLD.WS) in Q3 2024, closing a stake of 17 shares.

Tower Research Capital (TRC) first reported a position in VLD.WS in Q3 2022 and held it in 8 quarters. The position peaked at $6 in Q2 2023. 1 fund tracked by Wall St. Rank holds VLD.WS as of Q3 2024.

  • Tower Research Capital (TRC) reported no remaining Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position as of Q3 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 17 Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 shares in Q3 2024.
  • Tower Research Capital (TRC) first reported a position in Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in Q3 2022 and held it in 8 quarters.
  • Tower Research Capital (TRC)'s Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position peaked at $6 in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 as of Q3 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2024, filed 14 Nov 2024.